Nebulizer Market: Information by Type (Jet Nebulizers, Mesh Nebulizers), End-User (Hospitals and Clinics, Emergency Centers, Home Healthcare) , and Region — Forecast till 2029

May 11, 2020   Market Overview Nebulizers change the liquid dosage to mist for easy inhalation. In other words, the process of converting a bulk liquid pneumatically into small aerosol droplets for inhalation purposes is called nebulization.  Nebulizers are commonly used as drug delivery devices for bronchodilators, chronic respiratory diseases, cystic fibrosis, asthma, and chronic obstructive pulmonary disorder (COPD). As per the World Health Organization (WHO), around 3 million deaths are reported each...
Request Free Sample Report

Report Description

Market Overview

Nebulizers change the liquid dosage to mist for easy inhalation. In other words, the process of converting a bulk liquid pneumatically into small aerosol droplets for inhalation purposes is called nebulization.  Nebulizers are commonly used as drug delivery devices for bronchodilators, chronic respiratory diseases, cystic fibrosis, asthma, and chronic obstructive pulmonary disorder (COPD). As per the World Health Organization (WHO), around 3 million deaths are reported each year due to COPDs, which is about 6% of all deaths across the world.

The nebulizer market was valued at USD 979.4 million in 2019 and is expected to grow with a CAGR of 6.8 % during the forecast period, 2020–2029.

Nebulizer-MarketGrowing Burden of Chronic Respiratory Diseases to Prompt the Need for Effective Nebulizer

Globally, the prevalence of asthma and COPD has been rising at an alarming rate, further prompting the need for effective nebulizers. As per the Centers for Disease Control and Prevention, in the U.S., COPD was the third major cause of death in 2015. Rising air pollution and the release of toxic gases are two prime factors for the rapid increase in COPD cases across the globe. Apart from this, the spread of infections such as tuberculosis, pneumonia, hospital-acquired respiratory infections, and COVID-19 prompt the need for nebulizers. In India, China, Brazil, Africa, and Eastern Europe, the cases of COPD are projected to rise beyond 100 million in the next few years.

Nebulizer-Market-Growth

Rising Geriatric Population and Increasing Demand for Home Healthcare Devices  

Nebulizer works by atomizing liquid dosage into inhalable aerosol and is considered an easy way to administer medicine, particularly in the geriatric and pediatric population. Nebulizers also swiftly dissipate the drugs into the lungs for it to enter the bloodstream and provide swift relief.  As per the Population Reference Bureau’s report, ‘Aging in the United States,’ in the U.S., the geriatric population is anticipated to increase from 48 million in 2016 to 98 million by 2060.

The geriatric population is highly susceptible to respiratory diseases such as COPD and sleep apnea, further rising the demand for home healthcare services and quick treatment. As per the UN estimates, in 2017, the global population aged 60 and above was about 962 million and is anticipated to reach 1.41 billion by 2030.  As per the Journal of the Italian Society of Gerontology and Geriatrics, in Europe, about 10% of the population aged 75 and above has COPD, further rising the need for home-based healthcare services.

Nebulizer Market: Segmentation

Nebulizer-Market-Segmentation

Jet Nebulizer Segment to Hold Three-Quarters of the Market Share

The jet nebulizer segment held the largest market share in 2018. As reported by Omron Corporation, one of the major market players in the nebulizer market, Jet nebulizers held 90% of the market share due to its cost-effectiveness and easy to use features. However, the jet nebulizers are comparatively heavy and noisy as it converts liquid medicines to mist, which might hamper the segment growth.

Quick Treatment, Portability, and Convenience to Drive the Segment Growth

The mesh nebulizers segment is expected to witness lucrative growth in the nebulizer during the forecast period due to technological advancement, compact sizes, and minimized drug loss. Increasing adoption due to quick treatment, portability, convenience, and accurate drug delivery to the lung and lower residual volumes drive the segment growth.

Mesh nebulizers are generally smaller and quicker than compressor nebulizers and can be used while lying down; however, they are expensive than compressor nebulizers. Some of the products offered by prominent market players include MicroAir U100 by Omron Corporation used for the treatment of lower respiratory tract diseases, and PARI LC SPRINT and PARI LC PLUS nebulizer developed by PARI Respiratory Equipment.

Increasing Awareness about Respiratory Disease Treatment and Rising Disposable Income to Drive the Segment Growth

The hospitals and clinics segment accounted for the largest market share in 2018 and is projected to dominate the market during the forecast period. Hospitals are backed by high-cost instruments, robust infrastructure, and trained personnel. Increasing awareness about respiratory disease treatment, coupled with rising disposable income drives the segment growth. Hospitals and clinics extensively use large quantities of nebulizers in the nurse’s station, operation theater room, emergency room, outpatient clinics, and hospital’s ambulatory services, further driving the market growth.

Shifting Patient Preference towards Homecare to Minimize Hospital Expenses Drives the Segment Growth

The home healthcare segment is expected to grow with a CAGR of 10.9% during the forecast period due to rising number of geriatric patients suffering from chronic respiratory diseases. Technological advancements in nebulizers influence patients to use convenient and user-friendly devices for the treatment of various pulmonary and respiratory diseases. In developed countries like the U.S. and U.K., the governments have streamlined reimbursement policies for home healthcare medical devices, including nebulizer devices, further driving the market growth. Shifting patient preference towards homecare to minimize hospital expenses drives the segment growth.

Impact of COVID 19

Globally, the rising prevalence of several respiratory diseases such as COVID 19, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS) prompt the dire need for effective nebulizers for quick delivery of sufficient drug with minimal wastage. The coronavirus primarily attacks the human respiratory system, further rising the need for nebulization therapy during the course of the treatment. Currently, the market is facing a shortage of nebulizers as companies and wholesalers are running out of stock due to disruption in the supply chain, further hampering the market growth.

Regional Overview

North-America-Lead-Nebulizer-Market

Introduction of Technologically Advanced Devices to Drive North America’s Market Growth

North America accounted for over 35% of the market share in 2019 on account of favorable reimbursement policies, surging awareness regarding treatment options, the introduction of technologically advanced devices, and presence of well-established healthcare infrastructure. Rising demand for portable nebulizer devices among patients with asthma and other respiratory diseases drives the regional market growth. In the U.S., increasing healthcare costs have compelled the government to introduce new strategies in order to reduce patient stays in hospitals, further driving the market growth.  

Rapidly Expanding Healthcare Infrastructure in India, China, and Japan to Drive Asia-Pacific’s Market Growth

Asia-Pacific is expected to witness the fastest growth in the nebulizer market due to the rising geriatric population, increasing focus on preventive care, and government initiatives to promote technological advancements. As per Japan’s Ministry of Health, Labor and Welfare, COPD was the third most common cause of death in the country in 2017.

Rapidly expanding healthcare infrastructure is subsequently increasing the demand for technologically advanced nebulizers in emerging countries like India, Japan, and China. As per the WHO, around three million people in Asia-Pacific suffered from COPD and asthmatic attacks in XXXX. As per the NCBI, in India, approximately 43,000 people died due to asthma in 2017. A recent study by Rehabilitation Center at Federal University shows that in most South Asian countries, the prevalence of asthma has increased due to allergic rhinitis and a high rate of tobacco smoking.

Key Players

  • Omron
  • Koninklijke Philips
  • PARI Respiratory Equipment
  • Allied Healthcare Products Inc.
  • Agilent Technologies, Inc.
  • CareFusion Corporation
  • GF Health Products, Inc.
  • DeVilbiss Healthcare
  • Aerogen

Recent Developments

  • In October 2018, PARI Respiratory Equipment attained the U.S. FDA approval for its e-FLOW technology device LAMIRA, which is the only nebulizer system to deliver amikacin liposome inhalation suspension. The nebulizer is used for the treatment of mycobacterium avium complex lung infection in adult patients.
  • In November 2018, Koninklijke Philips unveiled portable nebulizer InnoSpire Go in the U.S.

Nebulizer Market Segmentation

By Type

  • Jet nebulizers
  • Mesh nebulizers
  • Ultrasonic nebulizers

By End-User

  • Hospitals and clinics
  • Emergency centers
  • Home healthcare

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The nebulizer market was valued at USD 979.4 million in 2019 and is expected to grow with a CAGR of 6.8 % during the forecast period, 2020–2029.
Rising demand for portable nebulizer devices among the patients with asthma and other respiratory diseases, increasing focus on preventive care are the key factors expected to drive Nebulizer Market during the forecast period.
North America is expected to hold the highest market share in Nebulizer Market.
Omron, Koninklijke Philips, PARI Respiratory Equipment, Allied Healthcare Products Inc., Agilent Technologies, Inc., CareFusion Corporation, GF Health Products, Inc. are the top players in Nebulizer Market.
In 2019 Global Nebulizer Market was valued at USD 979.4 million.
Jet Nebulizer Segment is expected to be the leading segment in Nebulizer Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

Market Overview

Nebulizers change the liquid dosage to mist for easy inhalation. In other words, the process of converting a bulk liquid pneumatically into small aerosol droplets for inhalation purposes is called nebulization.  Nebulizers are commonly used as drug delivery devices for bronchodilators, chronic respiratory diseases, cystic fibrosis, asthma, and chronic obstructive pulmonary disorder (COPD). As per the World Health Organization (WHO), around 3 million deaths are reported each year due to COPDs, which is about 6% of all deaths across the world.

The nebulizer market was valued at USD 979.4 million in 2019 and is expected to grow with a CAGR of 6.8 % during the forecast period, 2020–2029.

Nebulizer-MarketGrowing Burden of Chronic Respiratory Diseases to Prompt the Need for Effective Nebulizer

Globally, the prevalence of asthma and COPD has been rising at an alarming rate, further prompting the need for effective nebulizers. As per the Centers for Disease Control and Prevention, in the U.S., COPD was the third major cause of death in 2015. Rising air pollution and the release of toxic gases are two prime factors for the rapid increase in COPD cases across the globe. Apart from this, the spread of infections such as tuberculosis, pneumonia, hospital-acquired respiratory infections, and COVID-19 prompt the need for nebulizers. In India, China, Brazil, Africa, and Eastern Europe, the cases of COPD are projected to rise beyond 100 million in the next few years.

Nebulizer-Market-Growth

Rising Geriatric Population and Increasing Demand for Home Healthcare Devices  

Nebulizer works by atomizing liquid dosage into inhalable aerosol and is considered an easy way to administer medicine, particularly in the geriatric and pediatric population. Nebulizers also swiftly dissipate the drugs into the lungs for it to enter the bloodstream and provide swift relief.  As per the Population Reference Bureau’s report, ‘Aging in the United States,’ in the U.S., the geriatric population is anticipated to increase from 48 million in 2016 to 98 million by 2060.

The geriatric population is highly susceptible to respiratory diseases such as COPD and sleep apnea, further rising the demand for home healthcare services and quick treatment. As per the UN estimates, in 2017, the global population aged 60 and above was about 962 million and is anticipated to reach 1.41 billion by 2030.  As per the Journal of the Italian Society of Gerontology and Geriatrics, in Europe, about 10% of the population aged 75 and above has COPD, further rising the need for home-based healthcare services.

Nebulizer Market: Segmentation

Nebulizer-Market-Segmentation

Jet Nebulizer Segment to Hold Three-Quarters of the Market Share

The jet nebulizer segment held the largest market share in 2018. As reported by Omron Corporation, one of the major market players in the nebulizer market, Jet nebulizers held 90% of the market share due to its cost-effectiveness and easy to use features. However, the jet nebulizers are comparatively heavy and noisy as it converts liquid medicines to mist, which might hamper the segment growth.

Quick Treatment, Portability, and Convenience to Drive the Segment Growth

The mesh nebulizers segment is expected to witness lucrative growth in the nebulizer during the forecast period due to technological advancement, compact sizes, and minimized drug loss. Increasing adoption due to quick treatment, portability, convenience, and accurate drug delivery to the lung and lower residual volumes drive the segment growth.

Mesh nebulizers are generally smaller and quicker than compressor nebulizers and can be used while lying down; however, they are expensive than compressor nebulizers. Some of the products offered by prominent market players include MicroAir U100 by Omron Corporation used for the treatment of lower respiratory tract diseases, and PARI LC SPRINT and PARI LC PLUS nebulizer developed by PARI Respiratory Equipment.

Increasing Awareness about Respiratory Disease Treatment and Rising Disposable Income to Drive the Segment Growth

The hospitals and clinics segment accounted for the largest market share in 2018 and is projected to dominate the market during the forecast period. Hospitals are backed by high-cost instruments, robust infrastructure, and trained personnel. Increasing awareness about respiratory disease treatment, coupled with rising disposable income drives the segment growth. Hospitals and clinics extensively use large quantities of nebulizers in the nurse’s station, operation theater room, emergency room, outpatient clinics, and hospital’s ambulatory services, further driving the market growth.

Shifting Patient Preference towards Homecare to Minimize Hospital Expenses Drives the Segment Growth

The home healthcare segment is expected to grow with a CAGR of 10.9% during the forecast period due to rising number of geriatric patients suffering from chronic respiratory diseases. Technological advancements in nebulizers influence patients to use convenient and user-friendly devices for the treatment of various pulmonary and respiratory diseases. In developed countries like the U.S. and U.K., the governments have streamlined reimbursement policies for home healthcare medical devices, including nebulizer devices, further driving the market growth. Shifting patient preference towards homecare to minimize hospital expenses drives the segment growth.

Impact of COVID 19

Globally, the rising prevalence of several respiratory diseases such as COVID 19, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS) prompt the dire need for effective nebulizers for quick delivery of sufficient drug with minimal wastage. The coronavirus primarily attacks the human respiratory system, further rising the need for nebulization therapy during the course of the treatment. Currently, the market is facing a shortage of nebulizers as companies and wholesalers are running out of stock due to disruption in the supply chain, further hampering the market growth.

Regional Overview

North-America-Lead-Nebulizer-Market

Introduction of Technologically Advanced Devices to Drive North America’s Market Growth

North America accounted for over 35% of the market share in 2019 on account of favorable reimbursement policies, surging awareness regarding treatment options, the introduction of technologically advanced devices, and presence of well-established healthcare infrastructure. Rising demand for portable nebulizer devices among patients with asthma and other respiratory diseases drives the regional market growth. In the U.S., increasing healthcare costs have compelled the government to introduce new strategies in order to reduce patient stays in hospitals, further driving the market growth.  

Rapidly Expanding Healthcare Infrastructure in India, China, and Japan to Drive Asia-Pacific’s Market Growth

Asia-Pacific is expected to witness the fastest growth in the nebulizer market due to the rising geriatric population, increasing focus on preventive care, and government initiatives to promote technological advancements. As per Japan’s Ministry of Health, Labor and Welfare, COPD was the third most common cause of death in the country in 2017.

Rapidly expanding healthcare infrastructure is subsequently increasing the demand for technologically advanced nebulizers in emerging countries like India, Japan, and China. As per the WHO, around three million people in Asia-Pacific suffered from COPD and asthmatic attacks in XXXX. As per the NCBI, in India, approximately 43,000 people died due to asthma in 2017. A recent study by Rehabilitation Center at Federal University shows that in most South Asian countries, the prevalence of asthma has increased due to allergic rhinitis and a high rate of tobacco smoking.

Key Players

  • Omron
  • Koninklijke Philips
  • PARI Respiratory Equipment
  • Allied Healthcare Products Inc.
  • Agilent Technologies, Inc.
  • CareFusion Corporation
  • GF Health Products, Inc.
  • DeVilbiss Healthcare
  • Aerogen

Recent Developments

  • In October 2018, PARI Respiratory Equipment attained the U.S. FDA approval for its e-FLOW technology device LAMIRA, which is the only nebulizer system to deliver amikacin liposome inhalation suspension. The nebulizer is used for the treatment of mycobacterium avium complex lung infection in adult patients.
  • In November 2018, Koninklijke Philips unveiled portable nebulizer InnoSpire Go in the U.S.

Nebulizer Market Segmentation

By Type

  • Jet nebulizers
  • Mesh nebulizers
  • Ultrasonic nebulizers

By End-User

  • Hospitals and clinics
  • Emergency centers
  • Home healthcare

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The nebulizer market was valued at USD 979.4 million in 2019 and is expected to grow with a CAGR of 6.8 % during the forecast period, 2020–2029.
Rising demand for portable nebulizer devices among the patients with asthma and other respiratory diseases, increasing focus on preventive care are the key factors expected to drive Nebulizer Market during the forecast period.
North America is expected to hold the highest market share in Nebulizer Market.
Omron, Koninklijke Philips, PARI Respiratory Equipment, Allied Healthcare Products Inc., Agilent Technologies, Inc., CareFusion Corporation, GF Health Products, Inc. are the top players in Nebulizer Market.
In 2019 Global Nebulizer Market was valued at USD 979.4 million.
Jet Nebulizer Segment is expected to be the leading segment in Nebulizer Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.